| Year |
Citation |
Score |
| 2015 |
Stancescu M, Molnar P, McAleer CW, McLamb W, Long CJ, Oleaga C, Prot JM, Hickman JJ. A phenotypic in vitro model for the main determinants of human whole heart function. Biomaterials. 60: 20-30. PMID 25978005 DOI: 10.1016/J.Biomaterials.2015.04.035 |
0.37 |
|
| 2015 |
Esch MB, Prot JM, Wang YI, Miller P, Llamas-Vidales JR, Naughton BA, Applegate DR, Shuler ML. Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. Lab On a Chip. 15: 2269-77. PMID 25857666 DOI: 10.1039/C5Lc00237K |
0.38 |
|
| 2014 |
Prot JM, Maciel L, Bricks T, Merlier F, Cotton J, Paullier P, Bois FY, Leclerc E. First pass intestinal and liver metabolism of paracetamol in a microfluidic platform coupled with a mathematical modeling as a means of evaluating ADME processes in humans. Biotechnology and Bioengineering. 111: 2027-40. PMID 24954399 DOI: 10.1002/Bit.25232 |
0.68 |
|
| 2013 |
Smith AS, Long CJ, Berry BJ, McAleer C, Stancescu M, Molnar P, Miller PG, Esch MB, Prot JM, Hickman JJ, Shuler ML. Microphysiological systems and low-cost microfluidic platform with analytics. Stem Cell Research & Therapy. 4: S9. PMID 24565109 DOI: 10.1186/Scrt370 |
0.404 |
|
| 2013 |
Baudoin R, Prot JM, Nicolas G, Brocheton J, Brochot C, Legallais C, Benech H, Leclerc E. Evaluation of seven drug metabolisms and clearances by cryopreserved human primary hepatocytes cultivated in microfluidic biochips. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 43: 140-52. PMID 22830982 DOI: 10.3109/00498254.2012.706725 |
0.698 |
|
| 2012 |
Ouattara DA, Prot JM, Bunescu A, Dumas ME, Elena-Herrmann B, Leclerc E, Brochot C. Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3A cells. Molecular Biosystems. 8: 1908-20. PMID 22618574 DOI: 10.1039/C2Mb25049G |
0.66 |
|
| 2012 |
Cheng S, Prot JM, Leclerc E, Bois FY. Zonation related function and ubiquitination regulation in human hepatocellular carcinoma cells in dynamic vs. static culture conditions. Bmc Genomics. 13: 54. PMID 22296956 DOI: 10.1186/1471-2164-13-54 |
0.59 |
|
| 2012 |
Shintu L, Baudoin R, Navratil V, Prot JM, Pontoizeau C, Defernez M, Blaise BJ, Domange C, Péry AR, Toulhoat P, Legallais C, Brochot C, Leclerc E, Dumas ME. Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs. Analytical Chemistry. 84: 1840-8. PMID 22242722 DOI: 10.1021/Ac2011075 |
0.709 |
|
| 2012 |
Prot JM, Bunescu A, Elena-Herrmann B, Aninat C, Snouber LC, Griscom L, Razan F, Bois FY, Legallais C, Brochot C, Corlu A, Dumas ME, Leclerc E. Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicology and Applied Pharmacology. 259: 270-80. PMID 22230336 DOI: 10.1016/J.Taap.2011.12.017 |
0.728 |
|
| 2012 |
Prot JM, Leclerc E. The current status of alternatives to animal testing and predictive toxicology methods using liver microfluidic biochips. Annals of Biomedical Engineering. 40: 1228-43. PMID 22160577 DOI: 10.1007/S10439-011-0480-5 |
0.643 |
|
| 2011 |
Prot JM, Briffaut AS, Letourneur F, Chafey P, Merlier F, Grandvalet Y, Legallais C, Leclerc E. Integrated proteomic and transcriptomic investigation of the acetaminophen toxicity in liver microfluidic biochip. Plos One. 6: e21268. PMID 21857903 DOI: 10.1371/Journal.Pone.0021268 |
0.76 |
|
| 2011 |
Prot JM, Aninat C, Griscom L, Razan F, Brochot C, Guillouzo CG, Legallais C, Corlu A, Leclerc E. Improvement of HepG2/C3a cell functions in a microfluidic biochip. Biotechnology and Bioengineering. 108: 1704-15. PMID 21337338 DOI: 10.1002/Bit.23104 |
0.728 |
|
| 2011 |
Prot JM, Videau O, Brochot C, Legallais C, Bénech H, Leclerc E. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening. International Journal of Pharmaceutics. 408: 67-75. PMID 21295126 DOI: 10.1016/J.Ijpharm.2011.01.054 |
0.765 |
|
| Show low-probability matches. |